Events
Broadcast via Facebook Live from XXIV World Congress of Neurology, Dubai, UAE, Monday, Oct. 28, 7:15 am EDT
The XXIV World Congress of Neurology is bringing together leading voices in migraine research and advocacy to share vital insights on the global impact of migraine in the workplace.
The road to caring for patients with epilepsy is leading to more effective options for patients of all ages, according to expert findings unveiled by members of the World Federation of Neurology.
PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and
Signant proud to take leadership role at 10th annual summit as key pioneers and thought leaders convene to advance the science and technology of CNS research
MaxCyte, the global cell-based therapies and life sciences company, announces two presentations at the 5th Annual Cell & Gene Therapy Congress taking place 29-30 October in London, UK, which showcase the Company’s cell therapy technology.
Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that advanced radiation therapy delivered within PetCure-developed treatment protocols is leading to better survival outcomes than other treatment options for at least nine specific tumor types.
Low-cost, flexible and dependable automation possibilities open up for any research group
MorphoSys AG will publish its first nine months’ 2019 results on October 29, 2019 at 10:00pm CET
The theme of the 2019 World Congress of Neurology (WCN 2019), Accelerating the Pace of Change, emphasizes the global effort to further neurological healthcare, and serves as a springboard to advance the field of neurology around the globe.
PRESS RELEASES